OMCAP CAP is a premium pharmaceutical formulation containing Omeprazole, a potent proton pump inhibitor designed to effectively treat acid-related gastrointestinal disorders. This medication is expertly formulated under the Dr Precision label by Bluepill Express, adhering to stringent WHO-GMP and ISO-certified manufacturing standards to ensure superior quality and safety. OMCAP CAP targets excessive gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in gastric parietal cells, making it highly effective for managing conditions such as gastroesophageal reflux disease (GERD), gastric and duodenal ulcers, erosive esophagitis, and Zollinger-Ellison syndrome. The delayed-release capsule design ensures optimal delivery to the small intestine, maximizing drug bioavailability and therapeutic efficacy while minimizing degradation in the stomach. OMCAP CAP facilitates rapid relief from symptoms like heartburn, regurgitation, and chronic cough, while promoting mucosal healing to prevent complications like bleeding and ulceration. Available in multiple pack sizes (10, 14, and 28 capsules) with customizable blister and alu-alu packaging, OMCAP CAP is ideal for third-party manufacturing, international export, and inclusion in government and hospital tender programs. Each production batch undergoes rigorous quality control, including dissolution profiling, stability testing, and microbiological assays, ensuring consistency, purity, and patient safety. This product fits seamlessly within pharmaceutical distribution channels such as hospital pharmacies, retail outlets, and e-pharmacies, making it a reliable choice for business-to-business partners looking to supply high-quality gastrointestinal therapies. While generally well tolerated, medical supervision is advised during prolonged use to monitor potential side effects such as nausea or nutrient deficiencies.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Omeprazole |
| Mechanism of Action | Proton pump inhibitor; inhibits H+/K+ ATPase in gastric parietal cells |
| Indications | GERD, gastric ulcers, duodenal ulcers, erosive esophagitis, Zollinger-Ellison syndrome |
| Dosage Form | Delayed-release oral capsules |
| Packaging Options | 10, 14, 28 capsules in blister or alu-alu packs |
| Manufacturing Standards | WHO-GMP compliant, ISO-certified, GMP precision under Dr Precision label |
| Quality Control | Dissolution profiling, stability testing, microbiological assays |
| Target Market | Third-party manufacturing, international export, hospital and retail pharma supply |
| Therapeutic Benefits | Reduces stomach acid, promotes mucosal healing, relieves heartburn and acid reflux symptoms |
| Safety Profile | Generally well tolerated; monitor for nausea, headache, hypomagnesemia on prolonged use |
| Attributes | Description |
|---|---|
| Active Substance Concentration | 20mg or 40mg Omeprazole per capsule (dependent on batch specs) |
| Formulation Type | Delayed-release enteric coated capsules |
| Shelf Life | 24 months from manufacturing date |
| Storage Conditions | Store in a cool, dry place, protected from light |
| Compliance Certifications | WHO-GMP, ISO 9001:2015, regulatory agency approvals |
| Packaging Material | Blister packs, Alu-Alu strips as per client customization |
| Recommended Usage | Oral, once daily preferably before meals |
| Manufacturer | Bluepill Express under the Dr Precision label |
| Target Dosage Population | Adults requiring acid reflux and ulcer treatment |
| Side Effects Monitoring | Nausea, flatulence, headache, constipation; long-term monitoring advised |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
OMCAP CAP is formulated as a delayed-release capsule, which ensures that the Omeprazole is protected from stomach acid and is released in the small intestine. This targeted release improves the drug's bioavailability and therapeutic efficiency by preventing premature degradation.
Yes, OMCAP CAP is available in multiple pack sizes such as 10, 14, and 28 capsules and can be customized with blister or alu-alu packaging, making it highly suitable for bulk supply, export, and international market distribution.
OMCAP CAP is produced under WHO-GMP and ISO-certified production protocols by Bluepill Express, with every batch undergoing rigorous quality control including dissolution profiling, stability testing, and microbiological assays to ensure consistent purity and potency.
Prolonged use of OMCAP CAP should be monitored for potential risks such as hypomagnesemia, bone density reduction, and Vitamin B12 deficiency, particularly in elderly patients, due to the sustained suppression of stomach acid affecting nutrient absorption.
OMCAP CAP meets regulatory and quality standards that qualify it for inclusion in government tenders, hospital procurement, and large-scale pharmaceutical supply chains, supporting broad accessibility in institutional settings.
Country Of Origin: India
OMCAP CAP contains Omeprazole, a proton pump inhibitor (PPI) used to treat conditions like acid reflux, gastric ulcers, heartburn, and GERD. It works by reducing stomach acid production, offering relief from gastrointestinal discomfort. Manufactured under strict GMP guidelines by Bluepill Express, it is ideal for third-party manufacturing and international market distribution.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
OMCAP CAP is a gastrointestinal support medication formulated with Omeprazole, a trusted and widely prescribed proton pump inhibitor (PPI) used in the treatment of acid-related disorders. It plays a vital role in reducing excessive stomach acid and is indicated for conditions such as gastroesophageal reflux disease (GERD), gastric ulcers, duodenal ulcers, erosive esophagitis, and Zollinger-Ellison syndrome.
Omeprazole works by blocking the H+/K+ ATPase enzyme system in the gastric parietal cells, which is responsible for acid secretion. By inhibiting this enzyme, OMCAP CAP significantly lowers gastric acid levels, providing relief from heartburn, regurgitation, chronic cough, and other symptoms associated with acid reflux. It also promotes healing of damaged mucosa in the esophagus and stomach lining, preventing further complications like bleeding or ulceration.
The capsule is typically taken once daily, preferably before meals, and is formulated for delayed release to ensure that the medication reaches the small intestine before it is activated. This increases its efficacy and bioavailability while reducing potential degradation in the stomach.
Manufactured by Bluepill Express, OMCAP CAP adheres to WHO-GMP, ISO-certified, and regulatory-compliant production protocols. Bluepill Express ensures that every capsule batch goes through rigorous quality checks, including dissolution profiling, stability testing, and microbiological assays to ensure purity, potency, and patient safety.
The product is available in 10, 14, and 28 capsule packs, with customizable blister or alu-alu packaging formats to meet the preferences of various international clients. OMCAP CAP is also suitable for inclusion in government tenders, hospital supply chains, retail pharma outlets, and ePharmacy platforms.
OMCAP CAP is generally well tolerated, though some individuals may experience side effects such as nausea, flatulence, headache, or constipation. Prolonged use should be monitored for risks such as hypomagnesemia, bone fractures, or Vitamin B12 deficiency, especially in elderly populations.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
